Corporate Governance

Documents & Charters

Board Members & Committees

Audit
Compensation
Governance
Science and Development
Wayne Pisano (Chairman of the Board)
Member
Member
Chair
Member
Deborah M. Brown, B.Sc., M.B.A.
Member
Chair
Bernd R. Seizinger, MD, PhD
Member
Chair
Angela Holtham, MBA, FCMA, FCPA, ICD.D
Chair
Member
Jonathan Rigby
Member
James T. Parsons
Member
Member
Matt Coffey, PhD, MBA

Board Diversity Matrix

The following Board Diversity Matrix presents our Board diversity statistics in accordance with Nasdaq Rule 5606, as self-disclosed by our directors. As we pursue future Board recruitment efforts, our Nominating and Corporate Governance Committee will continue to seek out candidates who can contribute to the diversity of views and perspectives of our Board.

As of: February 25, 2022
Country of Principal Executive Offices: Canada
Foreign Private Issuer Yes
Disclosure Prohibited Under Home Country Law No
Total Number of Directors 6

Gender Identity: Female Male
Directors 2 4
Demographic Background:    
Underrepresented Individual in Home Country Jurisdiction -
LGBTQ+ 1
Did Not Disclose Demographic Background 1

Investor Relations Contact

Jon Patton
Director of Investor Relations & Communication
Tel:+1-858-886-7813
Email: jpatton@oncolytics.ca

Email Alerts Sign-Up